Lars Pape, Germany
IPTA Councilor

Anette Melk, Germany
IPTA Councilor

Mignon I McCulloch, South Africa
Welcome to the Virtual IPTA 2022 Congress

Carlos O. Esquivel, United States
Welcome from the IPTA President

Dmytro D. Ivanov, Ukraine
The current situation of transplanted children in Ukraine

Tomas Seeman, Czech Republic
Welcome from Prague Organizing Chair and Concert by local transplant patients

Mignon I McCulloch, South Africa
Presidential Adress from IPTA Past President

Emily A. Blumberg, United States
Pandemic and Transplantation: Lessons learned from COVID-19

Su young Hong, Korea
Renal Replacement Therapy Is An Alarm Sign of Survival Outcome in Pediatric Liver Transplantation

Eui Soo Han, Korea
Long-term outcomes of left lateral segment grafts in low-weight pediatric recipients liver transplantation: comparing reduced versus full grafts

Florian Brinkert, Germany
Clinical outcome after combined liver and kidney transplantation in children in europe – a CERTAIN registry analysis

Katherine Harmann, United States
Immunizing pediatric liver transplant recipients against varicella virus using live-attenuated vaccination

Proshad Efune, United States
Intraoperative fluid administration during pediatric liver transplant surgery and postoperative outcomes: a retrospective multi-center analysis

Christine Hwang, United States
Pediatric Donation after Cardiac Death (DCD) Livers transplanted in adult recipients – appropriate utilization or missed opportunity for waitlisted children?

Olivia M Martinez, United States
Mutations in Latent Membrane Protein 1 of Epstein Barr Virus are Associated with Increased Risk of Post-transplant Lymphoproliferative Disorder

Masaki Yamada, Japan
Early detection of Epstein Barr virus and cytomegalovirus seronegative donors are the risk factors of chronic high Epstein-Barr viral load carriage after pediatric living-donor-dominated liver transplantation program.

Joao Seda Neto, Brazil
Unresectable hepatoblastoma and pre-transplant factors associated with event-free survival

Jorge Arroyo Orvañanos, Mexico
Cytomegalovirus Infection and Disease in Pediatric Liver Transplantation: Burden of Disease Under a Preemptive Therapy Approach

Helena Genberg, Sweden
Single-dose rituximab induction may prevent EBV viremia in paediatric kidney recipients long-term: an investigation from the Nordic Paediatric Renal Transplantation Study Group (NPRTSG)

Olga Charnaya, United States
Risk of Post-Transplant Malignancy in Pediatric Kidney Transplant Recipients is not Influenced by Induction Immunosuppression

Roberto Tambucci, Belgium
Is ABO incompatible living donor liver transplantation really a good alternative for pediatric recipients?

Alisha Mavis, United States
Do Surveillance Liver Biopsies Alter the Immunosuppression Regimen in Pediatric Liver Transplant Recipients?

Thurid Ahlenstiel-Grunow, Germany
Steering of immunosuppression by virus-specific T cells after pediatric kidney transplantation in the randomized controlled IVIST trial

Paul Grimm, United States
Sequential hematopoietic stem cell transplantation (HSCT) followed by kidney transplant- 3 children who received αβT-cell/CD19 B-cell depleted HSCT followed by kidney transplant from same parental donor are rejection free and immunosuppression free with donor specific tolerance > 1year post kidney transplant

Mary M Chandran, United States
Impact of once-daily extended-release tacrolimus intrapatient variability in stable adolescent and young adult renal transplant recipients – 3 year results

Ashlene McKay, Canada
LDL apheresis for FSGS recurrence in pediatric kidney transplant recipients: A case series

Mureo Kasahara, Japan
Use of non-conventional organs Monosegmental liver Living donation: A necessary technical evolution to care for the very small?

Blayne Amir Sayed, Canada
Living donation: Living donation for acute liver failure- is this possible and ethically acceptable?

Gordon Thomas, Australia
High risk organs and Livers from DCDs: When should these be considered in pediatrics?

Ruth McDonald, United States
PTLD prediction based on Epstein-Barr viral loads

Hui Kim Yap, Singapore
Improving access to transplantation internationally

Paul Grimm, United States
Making the right decision in accepting deceased donor organ offers at 3am

Taizo Hibi, Japan
The future options to expand the donor pool (living donor, dcd, perfusion)

Yaron Avitzur, Canada
Intestinal rehabilitation and intestinal failure: When to transplant

Jennifer Garcia, United States
Intestinal Transplant Puzzle: Picking the right pieces

Valeria R. Mas, United States
CRISPR and Transplantation

Hossein Tabriziani, United States

Sara Jandeska, United States

Mignon I McCulloch, South Africa
IPTA 2022 Virtual Toast

Tomas Seeman, Czech Republic
Prague Trivia Game

Felicia Kjaernet, Sweden
Long-term outcome and complications in paediatric ABO-incompatible living donor kidney transplantation with rituximab induction: A multi-centre investigation from the Nordic Paediatric Renal Transplantation Study Group (NPRTSG)

Dechu Puliyanda, United States
Long term tolerability and clinical outcomes associated with Tocilizumab (TCZ) therapy in the treatment of refractory antibody mediated rejection (ABMR) in 25 pediatric renal transplant recipients

Asha Moudgil, United States
Prevalence of Mycophenolate Mofetil discontinuation and subsequent outcomes in pediatric kidney transplant recipients: a PNRC study

Hyunwoong Chae, Canada
Adrenal insufficiency in pediatric kidney transplant recipients

Charlotte E Withers, United Kingdom
National study on the risks of COVID-19 for paediatric renal transplant recipients

Femke HM Vrieling-Prince, Netherlands
Renal graft loss during adolescence: is there a relationship between pubertal stage and activity of the immune system?

Saba Masood, United States
A qualitative examination of posttraumatic stress symptoms in pediatric solid organ transplant patients: What is the traumatic stressor and how do the symptoms manifest?

Kelli N Triplett PhD ABPP, United States
Q&A discussion on behalf of Saba Masood

Elizabeth S Christofferson, United States
Disparities and Barriers Associated with Pediatric Transplant Evaluation: A Comprehensive Analysis of the Impact on Time to Listing

Catherine Patterson, Canada
Allied health and nursing practices in pediatric solid organ transplantation: An international survey

Robin Deliva, Canada
Functional performance in pediatric heart transplant candidates and recipients: a retrospective review

Nikol K. Grishin, Canada
VEXT-A Virtual Exercise Training Program for Solid Organ Transplant Recipients

Jo Wray, United Kingdom
Quality of life of paediatric cardiothoracic transplant patients: parent-child agreement and association with family impact

Esra Baskin, Turkey
Long Term Effects of Eplerenone Treatment in Children with Chronic Allograft Dysfunction

Gabor A. Dunay, Germany
The role of tissue resident memory T cells in pediatric liver transplantation

Huib de Jong, Netherlands
Neutrophil gelatinase-associated lipocalin (NGAL) and Interleukine-18 (IL-18) in graft urine correlate with the rate of recovery of transplanted kidneys in children

Arpit Amin, United States
Kidney transplant in pediatric gut transplant recipients – Technical Challenges and Outcomes

Raphael Schild, Germany
Outcome after pediatric kidney transplantation from very small donors: a match-controlled CERTAIN Registry study.

Christine Hwang, United States
Delayed Graft Function In Pediatric Living Donor Kidney Transplantation

Grainne M Walsh, United Kingdom
Patient Voices Video / Interviewer: Grainne Walsh, UK / Patient: Cecilia

Cassandra Smith-Fields, United States
Can we afford QI in transplant - administrator perspective

David K. Hooper, United States
Value of outcomes improvements through learning healthcare systems KIDNEY

George V. Mazariegos, United States
Value of outcomes improvements through learning healthcare systems LIVER

Hayley Altman Gans, United States
IPTA Councilor

Andre Dick, United States
IPTA Councilor